Rotigotine D7 Hydrochloride
| Product Name | Rotigotine D7 Hydrochloride |
|---|---|
| Alternate Names | Rotigotine Stable Isotopes, Stable Isotopes of Rotigotine |
| CAT No. | CS-O-03341 |
| CAS No. | 2070009-57-1 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 358.98 g/mol |
| Mol. For. | C₁₉H₁₉D₇ClNOS |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Rotigotine |
| Purity | >98% |
| Therapeutic | Anti-Parkinsons |
| Smileys | OC1=C(CC[C@H](N(C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])CCC2=CC=CS2)C3)C3=CC=C1.Cl |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Rotigotine D7 Hydrochloride is a medication used to treat Parkinson's disease and restless leg syndrome. It works by stimulating dopamine receptors in the brain, which helps to improve movement and reduce symptoms such as tremors and rigidity. This medication is available in the form of a transdermal patch, which is applied to the skin and delivers a continuous dose of the medication over a 24-hour period.
Chemically, Rotigotine D7 Hydrochloride is a selective dopamine receptor agonist and is a deuterated analogue of Rotigotine Hydrochloride. The deuterated form is used in clinical studies to assist in drug metabolism and pharmacokinetic studies. The molecular formula of Rotigotine D7 Hydrochloride is C19H27D7ClN2O2, and it has a molecular weight of 365.98 g/mol.
Rotigotine D7 Hydrochloride is metabolized in the liver and excreted through the kidneys. It has a half-life of approximately 5-7 hours. The medication should be used with caution in patients with liver or kidney disease, as well as in patients with a history of mental health disorders.
In conclusion, Rotigotine D7 Hydrochloride is a medication used to treat Parkinson's disease and restless leg syndrome by stimulating dopamine receptors in the brain. It is available in the form of a transdermal patch and is metabolized in the liver and excreted through the kidneys. As with any medication, it should be used with caution and under the guidance of a healthcare provider.
Get an Instant Quote
Related Compounds
Rotigotine D7 | N-Nitroso Rac-Rotigotine USP Related Compound C D5 | N-Nitroso Rac-Rotigotine EP Impurity B D5 | rac Rotigotine-d3 Hydrochloride Salt | N-Nitroso Rotigotine USP Related Compound C-D4 | N-Ethyl Rotigotine-D5 | N-nitroso Rotigotine impurity B-D7 | rac-Rotigotine-d3 Methyl Ether Amide | rac-Rotigotine-d3 Methyl Ether |